Literature DB >> 23564346

Bimodal quantitative relationships between histone modifications for X-linked and autosomal loci.

Ruslan I Sadreyev1, Eda Yildirim, Stefan F Pinter, Jeannie T Lee.   

Abstract

Gene expression is controlled by coordinated action of many epigenetic mechanisms including covalent histone modifications. Although numerous recurrent patterns of colocalized histone modifications have been associated with specific gene expression states, interrelationships between individual modifications are largely unknown. Here, we analyze quantitative relationships between colocalized histone marks during embryonic stem cell (ESC) differentiation and find that, for autosomal genes, these densities follow bimodal patterns. Analysis of repressive H3K27me3 and activating H3K4me3 modifications reveals the expected anticorrelation between them at active promoters but an unexpected positive correlation at inactive promoters. The two trends connect in a region corresponding to bivalent genes. Interestingly, this region is characterized by maximal H3K27 methylation. Resolving gene bivalency during ESC differentiation does not conform to the expected model of two marks as counteracting and competing forces. Although activated genes acquire H3K4me3 and lose H3K27me3, repressed genes lose H3K4me3 without gaining H3K27me3. The behavior of X-linked genes also deviates from expected models. Allele-specific analysis of chromatin modifications during X-chromosome inactivation (XCI) suggests that the silencing machinery focuses on active genes and depletion of H3K4me3 and that H3K27me3 is most significant during establishment of gene silencing. Our analysis reveals nontrivial relationships between H3K4me3 and H3K27me3, reveals unique aspects of gene bivalency, and demonstrates that XCI does not conform neatly to autosomal models.

Mesh:

Substances:

Year:  2013        PMID: 23564346      PMCID: PMC3637770          DOI: 10.1073/pnas.1216449110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Polycomb group proteins set the stage for early lineage commitment.

Authors:  Lauren E Surface; Seraphim R Thornton; Laurie A Boyer
Journal:  Cell Stem Cell       Date:  2010-09-03       Impact factor: 24.633

Review 2.  Combinatorial complexity in chromatin structure and function: revisiting the histone code.

Authors:  Oliver J Rando
Journal:  Curr Opin Genet Dev       Date:  2012-03-20       Impact factor: 5.578

3.  Cell fate potential of human pluripotent stem cells is encoded by histone modifications.

Authors:  Seok-Ho Hong; Shravanti Rampalli; Jung Bok Lee; Jamie McNicol; Tony Collins; Jonathan S Draper; Mickie Bhatia
Journal:  Cell Stem Cell       Date:  2011-07-08       Impact factor: 24.633

Review 4.  Bivalent histone modifications in early embryogenesis.

Authors:  Nadine L Vastenhouw; Alexander F Schier
Journal:  Curr Opin Cell Biol       Date:  2012-04-17       Impact factor: 8.382

Review 5.  Molecular signals of epigenetic states.

Authors:  Roberto Bonasio; Shengjiang Tu; Danny Reinberg
Journal:  Science       Date:  2010-10-29       Impact factor: 47.728

6.  Spreading of X chromosome inactivation via a hierarchy of defined Polycomb stations.

Authors:  Stefan F Pinter; Ruslan I Sadreyev; Eda Yildirim; Yesu Jeon; Toshiro K Ohsumi; Mark Borowsky; Jeannie T Lee
Journal:  Genome Res       Date:  2012-09-04       Impact factor: 9.043

7.  Chromatin measurements reveal contributions of synthesis and decay to steady-state mRNA levels.

Authors:  Sylvia C Tippmann; Robert Ivanek; Dimos Gaidatzis; Anne Schöler; Leslie Hoerner; Erik van Nimwegen; Peter F Stadler; Michael B Stadler; Dirk Schübeler
Journal:  Mol Syst Biol       Date:  2012-07-17       Impact factor: 11.429

8.  GC-rich sequence elements recruit PRC2 in mammalian ES cells.

Authors:  Eric M Mendenhall; Richard P Koche; Thanh Truong; Vicky W Zhou; Biju Issac; Andrew S Chi; Manching Ku; Bradley E Bernstein
Journal:  PLoS Genet       Date:  2010-12-09       Impact factor: 5.917

9.  Modeling the relative relationship of transcription factor binding and histone modifications to gene expression levels in mouse embryonic stem cells.

Authors:  Chao Cheng; Mark Gerstein
Journal:  Nucleic Acids Res       Date:  2011-09-16       Impact factor: 16.971

10.  X-chromosome hyperactivation in mammals via nonlinear relationships between chromatin states and transcription.

Authors:  Eda Yildirim; Ruslan I Sadreyev; Stefan F Pinter; Jeannie T Lee
Journal:  Nat Struct Mol Biol       Date:  2011-12-04       Impact factor: 15.369

View more
  5 in total

1.  Xist RNA repeat E is essential for ASH2L recruitment to the inactive X and regulates histone modifications and escape gene expression.

Authors:  Minghui Yue; Akiyo Ogawa; Norishige Yamada; John Lalith Charles Richard; Artem Barski; Yuya Ogawa
Journal:  PLoS Genet       Date:  2017-07-07       Impact factor: 5.917

2.  Genome-wide identification of autosomal genes with allelic imbalance of chromatin state.

Authors:  Andrej J Savol; Peggy I Wang; Yesu Jeon; David Colognori; Eda Yildirim; Stefan F Pinter; Bernhard Payer; Jeannie T Lee; Ruslan I Sadreyev
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

3.  Genetic and epigenetic features direct differential efficiency of Xist-mediated silencing at X-chromosomal and autosomal locations.

Authors:  Agnese Loda; Johannes H Brandsma; Ivaylo Vassilev; Nicolas Servant; Friedemann Loos; Azadeh Amirnasr; Erik Splinter; Emmanuel Barillot; Raymond A Poot; Edith Heard; Joost Gribnau
Journal:  Nat Commun       Date:  2017-09-25       Impact factor: 14.919

4.  Deletion of an X-inactivation boundary disrupts adjacent gene silencing.

Authors:  Lindsay M Horvath; Nan Li; Laura Carrel
Journal:  PLoS Genet       Date:  2013-11-21       Impact factor: 5.917

Review 5.  Variable escape from X-chromosome inactivation: identifying factors that tip the scales towards expression.

Authors:  Samantha B Peeters; Allison M Cotton; Carolyn J Brown
Journal:  Bioessays       Date:  2014-06-10       Impact factor: 4.345

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.